HLA DR LOCUS (CLASS II), EDTA BLOOD

image not found

NABL Cap Accredited     
HLA DR Locus typing identifies specific Class II human leukocyte antigen variants using EDTA blood. It is an essential test for organ and bone marrow transplantation, ensuring donor-recipient compatibility and reducing the risk of rejection. The test also aids in assessing genetic susceptibility to autoimmune disorders. Metropolis Healthcare performs this test using advanced molecular techniques to provide accurate and high-resolution results for clinical and transplant decision-making

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,360.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: H0226

Frequently Asked Questions (FAQ's):

What does HLA DR locus typing detect?
It identifies specific Class II HLA alleles, important for transplant compatibility and autoimmune risk assessment.

Who should undergo this test?
Patients awaiting organ or bone marrow transplantation, and individuals being evaluated for autoimmune conditions.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-resolution molecular HLA typing techniques on EDTA blood samples.

What type of sample is required?
An EDTA-anticoagulated blood sample collected through routine venipuncture.

Is fasting required for this test?
No fasting or special preparation is needed.

What does a positive result indicate?
It identifies the presence of specific HLA DR alleles to aid donor matching and assess autoimmune risk.

Can this test guide transplant decisions?
Yes, it helps clinicians plan donor selection and post-transplant management.

How soon are results available from Metropolis Healthcare?
Results are usually available within 3–5 working days

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab